Chronic myeloid leukemia, version 1.2019

Jerald P. Radich, Michael Deininger, Camille N. Abboud, Jessica K. Altman, Ellin Berman, Ravi Bhatia, Bhavana Bhatnagar, Peter Curtin, Daniel J. DeAngelo, Jason Gotlib, Gabriela Hobbs, Madan Jagasia, Hagop M. Kantarjian, Lori J Maness-Harris, Leland Metheny, Joseph O. Moore, Arnel Pallera, Philip Pancari, Mrinal Patnaik, Enkhtsetseg PurevMichal G. Rose, Neil P. Shah, B. Douglas Smith, David S. Snyder, Kendra L. Sweet, Moshe Talpaz, James Thompson, David T. Yang, Kristina M. Gregory, Hema Sundar

Research output: Contribution to journalReview article

59 Scopus citations

Abstract

Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome (Ph), resulting from a reciprocal translocation between chromosomes 9 and 22 [t(9;22] that gives rise to a BCR-ABL1 fusion gene. CML occurs in 3 different phases (chronic, accelerated, and blast phase) and is usually diagnosed in the chronic phase. Tyrosine kinase inhibitor (TKI) therapy is a highly effective first-line treatment option for all patients with newly diagnosed chronic phase CML (CP-CML). The selection TKI therapy should be based on the risk score, toxicity profile of TKI, patient’s age, ability to tolerate therapy, and the presence of comorbid conditions. This manuscript discusses the recommendations outlined in the NCCN Guidelines for the diagnosis and management of patients with CP-CML.

Original languageEnglish (US)
Pages (from-to)1108-1135
Number of pages28
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number9
DOIs
StatePublished - Sep 1 2018

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Chronic myeloid leukemia, version 1.2019'. Together they form a unique fingerprint.

  • Cite this

    Radich, J. P., Deininger, M., Abboud, C. N., Altman, J. K., Berman, E., Bhatia, R., Bhatnagar, B., Curtin, P., DeAngelo, D. J., Gotlib, J., Hobbs, G., Jagasia, M., Kantarjian, H. M., Maness-Harris, L. J., Metheny, L., Moore, J. O., Pallera, A., Pancari, P., Patnaik, M., ... Sundar, H. (2018). Chronic myeloid leukemia, version 1.2019. JNCCN Journal of the National Comprehensive Cancer Network, 16(9), 1108-1135. https://doi.org/10.6004/jnccn.2018.0071